{
  "DOI": "10.1007/s10689-018-00115-3",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-018-00115-3",
  "alternative-id": [
    "115"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 1,
      "value": "18 January 2019"
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Visser",
      "given": "Mijke",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "van der Stoep",
      "given": "Nienke",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-5210-9150",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Gruis",
      "given": "Nelleke",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        1,
        18
      ]
    ],
    "date-time": "2019-01-18T04:30:20Z",
    "timestamp": 1547785820000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        1,
        18
      ]
    ],
    "date-time": "2020-01-18T00:12:48Z",
    "timestamp": 1579306368000
  },
  "funder": [
    {
      "DOI": "10.13039/501100004622",
      "award": [
        "UL2012-5489"
      ],
      "doi-asserted-by": "crossref",
      "name": "KWF Kankerbestrijding"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        3,
        25
      ]
    ],
    "date-time": "2023-03-25T13:30:13Z",
    "timestamp": 1679751013471
  },
  "is-referenced-by-count": 4,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2019,
        1,
        18
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2019,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            1,
            18
          ]
        ],
        "date-time": "2019-01-18T00:00:00Z",
        "timestamp": 1547769600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-018-00115-3/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-018-00115-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-018-00115-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "267-271",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2019,
        1,
        18
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        1,
        18
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2019,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/S0140-6736(18)31559-9",
      "author": "D Schadendorf",
      "doi-asserted-by": "publisher",
      "first-page": "971",
      "issue": "10151",
      "journal-title": "Lancet (London, England)",
      "key": "115_CR1",
      "unstructured": "Schadendorf D, van Akkooi ACJ, Berking C et al (2018) Melanoma. Lancet (London, England) 392(10151):971–984. \n                    https://doi.org/10.1016/s0140-6736(18)31559-9",
      "volume": "392",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.ejca.2004.10.016",
      "author": "S Gandini",
      "doi-asserted-by": "publisher",
      "first-page": "45",
      "issue": "1",
      "journal-title": "Eur J Cancer (Oxford, England: 1990)",
      "key": "115_CR2",
      "unstructured": "Gandini S, Sera F, Cattaruzza MS et al (2005) Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer (Oxford, England: 1990) 41(1):45–60. \n                    https://doi.org/10.1016/j.ejca.2004.10.016",
      "volume": "41",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.cell.2012.06.024",
      "author": "E Hodis",
      "doi-asserted-by": "publisher",
      "first-page": "251",
      "issue": "2",
      "journal-title": "Cell",
      "key": "115_CR3",
      "unstructured": "Hodis E, Watson IR, Kryukov GV et al (2012) A landscape of driver mutations in melanoma. Cell 150(2):251–263. \n                    https://doi.org/10.1016/j.cell.2012.06.024",
      "volume": "150",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.ejca.2005.03.034",
      "author": "S Gandini",
      "doi-asserted-by": "publisher",
      "first-page": "2040",
      "issue": "14",
      "journal-title": "Eur J Cancer (Oxford, England: 1990)",
      "key": "115_CR4",
      "unstructured": "Gandini S, Sera F, Cattaruzza MS et al (2005) Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer (Oxford, England: 1990) 41(14):2040–2059. \n                    https://doi.org/10.1016/j.ejca.2005.03.034",
      "volume": "41",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.jaad.2009.03.016",
      "author": "SA Leachman",
      "doi-asserted-by": "publisher",
      "first-page": "677.e1",
      "issue": "4",
      "journal-title": "J Am Acad Dermatol",
      "key": "115_CR5",
      "unstructured": "Leachman SA, Carucci J, Kohlmann W et al (2009) Selection criteria for genetic assessment of patients with familial melanoma. J Am Acad Dermatol 61(4):677.e1–677.e14 \n                    https://doi.org/10.1016/j.jaad.2009.03.016",
      "volume": "61",
      "year": "2009"
    },
    {
      "DOI": "10.1111/pcmr.12333",
      "author": "LG Aoude",
      "doi-asserted-by": "publisher",
      "first-page": "148",
      "issue": "2",
      "journal-title": "Pigm Cell Melanoma Res",
      "key": "115_CR6",
      "unstructured": "Aoude LG, Wadt KA, Pritchard AL, Hayward NK (2015) Genetics of familial melanoma: 20 years after CDKN2A. Pigm Cell Melanoma Res 28(2):148–160. \n                    https://doi.org/10.1111/pcmr.12333",
      "volume": "28",
      "year": "2015"
    },
    {
      "DOI": "10.1136/jmedgenet-2015-103150",
      "author": "J Read",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "1",
      "journal-title": "J Med Genet",
      "key": "115_CR7",
      "unstructured": "Read J, Wadt KA, Hayward NK (2016) Melanoma genetics. J Med Genet 53(1):1–14. \n                    https://doi.org/10.1136/jmedgenet-2015-103150",
      "volume": "53",
      "year": "2016"
    },
    {
      "DOI": "10.1126/science.8153634",
      "author": "A Kamb",
      "doi-asserted-by": "publisher",
      "first-page": "436",
      "issue": "5157",
      "journal-title": "Science",
      "key": "115_CR8",
      "unstructured": "Kamb A, Gruis NA, Weaver-Feldhaus J et al (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264(5157):436–440",
      "volume": "264",
      "year": "1994"
    },
    {
      "DOI": "10.1038/ng0196-97",
      "author": "L Zuo",
      "doi-asserted-by": "publisher",
      "first-page": "97",
      "issue": "1",
      "journal-title": "Nat Genet",
      "key": "115_CR9",
      "unstructured": "Zuo L, Weger J, Yang Q et al (1996) Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 12(1):97–99. \n                    https://doi.org/10.1038/ng0196-97",
      "volume": "12",
      "year": "1996"
    },
    {
      "DOI": "10.1136/jmedgenet-2012-101455",
      "author": "HE Puntervoll",
      "doi-asserted-by": "publisher",
      "first-page": "264",
      "issue": "4",
      "journal-title": "J Med Genet",
      "key": "115_CR10",
      "unstructured": "Puntervoll HE, Yang XR, Vetti HH et al (2013) Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants. J Med Genet 50(4):264–270 \n                    https://doi.org/10.1136/jmedgenet-2012-101455",
      "volume": "50",
      "year": "2013"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-06-0494",
      "author": "AM Goldstein",
      "doi-asserted-by": "publisher",
      "first-page": "9818",
      "issue": "20",
      "journal-title": "Cancer Res",
      "key": "115_CR11",
      "unstructured": "Goldstein AM, Chan M, Harland M et al (2006) High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res 66(20):9818–9828. \n                    https://doi.org/10.1158/0008-5472.Can-06-0494",
      "volume": "66",
      "year": "2006"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-08-0403",
      "author": "FA Snoo de",
      "doi-asserted-by": "publisher",
      "first-page": "7151",
      "issue": "21",
      "journal-title": "Clin Cancer Res",
      "key": "115_CR12",
      "unstructured": "de Snoo FA, Bishop DT, Bergman W et al (2008) Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families. Clin Cancer Res 14(21):7151–7157. \n                    https://doi.org/10.1158/1078-0432.Ccr-08-0403",
      "volume": "14",
      "year": "2008"
    },
    {
      "DOI": "10.1038/ejhg.2014.187",
      "author": "TP Potjer",
      "doi-asserted-by": "publisher",
      "first-page": "711",
      "issue": "5",
      "journal-title": "Eur J Hum Genet EJHG",
      "key": "115_CR13",
      "unstructured": "Potjer TP, Kranenburg HE, Bergman W et al (2015) Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variant. Eur J Hum Genet EJHG 23(5):711–714. \n                    https://doi.org/10.1038/ejhg.2014.187",
      "volume": "23",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ng.910",
      "author": "T Wiesner",
      "doi-asserted-by": "publisher",
      "first-page": "1018",
      "issue": "10",
      "journal-title": "Nat Genet",
      "key": "115_CR14",
      "unstructured": "Wiesner T, Obenauf AC, Murali R et al (2011) Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 43(10):1018–1021. \n                    https://doi.org/10.1038/ng.910",
      "volume": "43",
      "year": "2011"
    },
    {
      "DOI": "10.1371/journal.pone.0072144",
      "author": "LG Aoude",
      "doi-asserted-by": "publisher",
      "first-page": "e72144",
      "issue": "8",
      "journal-title": "PLoS ONE",
      "key": "115_CR15",
      "unstructured": "Aoude LG, Wadt K, Bojesen A et al (2013) A BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancers. PLoS ONE 8(8):e72144. \n                    https://doi.org/10.1371/journal.pone.0072144",
      "volume": "8",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.cancergen.2013.05.018",
      "author": "M Cheung",
      "doi-asserted-by": "publisher",
      "first-page": "206",
      "issue": "5",
      "journal-title": "Cancer Genet",
      "key": "115_CR16",
      "unstructured": "Cheung M, Talarchek J, Schindeler K et al (2013) Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma. Cancer Genet 206(5):206–210. \n                    https://doi.org/10.1016/j.cancergen.2013.05.018",
      "volume": "206",
      "year": "2013"
    },
    {
      "DOI": "10.18632/oncotarget.20465",
      "author": "M Lin",
      "doi-asserted-by": "publisher",
      "first-page": "74936",
      "issue": "43",
      "journal-title": "Oncotarget",
      "key": "115_CR17",
      "unstructured": "Lin M, Zhang L, Hildebrandt MAT, Huang M, Wu X, Ye Y (2017) Common, germline genetic variations in the novel tumor suppressor BAP1 and risk of developing different types of cancer. Oncotarget 8(43):74936–74946. \n                    https://doi.org/10.18632/oncotarget.20465",
      "volume": "8",
      "year": "2017"
    },
    {
      "DOI": "10.1038/ng.411",
      "author": "DT Bishop",
      "doi-asserted-by": "publisher",
      "first-page": "920",
      "issue": "8",
      "journal-title": "Nat Genet",
      "key": "115_CR18",
      "unstructured": "Bishop DT, Demenais F, Iles MM et al (2009) Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 41(8):920–925. \n                    https://doi.org/10.1038/ng.411",
      "volume": "41",
      "year": "2009"
    },
    {
      "DOI": "10.1038/nature10630",
      "author": "S Yokoyama",
      "doi-asserted-by": "publisher",
      "first-page": "99",
      "issue": "7375",
      "journal-title": "Nature",
      "key": "115_CR19",
      "unstructured": "Yokoyama S, Woods SL, Boyle GM et al (2011) A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature 480(7375):99–103. \n                    https://doi.org/10.1038/nature10630",
      "volume": "480",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nature10539",
      "author": "C Bertolotto",
      "doi-asserted-by": "publisher",
      "first-page": "94",
      "issue": "7375",
      "journal-title": "Nature",
      "key": "115_CR20",
      "unstructured": "Bertolotto C, Lesueur F, Giuliano S et al (2011) A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 480(7375):94–98. \n                    https://doi.org/10.1038/nature10539",
      "volume": "480",
      "year": "2011"
    },
    {
      "DOI": "10.1038/ng.959",
      "author": "JH Barrett",
      "doi-asserted-by": "publisher",
      "first-page": "1108",
      "issue": "11",
      "journal-title": "Nat Genet",
      "key": "115_CR21",
      "unstructured": "Barrett JH, Iles MM, Harland M et al (2011) Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet 43(11):1108–1113. \n                    https://doi.org/10.1038/ng.959",
      "volume": "43",
      "year": "2011"
    },
    {
      "DOI": "10.1038/ng.2947",
      "author": "CD Robles-Espinoza",
      "doi-asserted-by": "publisher",
      "first-page": "478",
      "issue": "5",
      "journal-title": "Nat Genet",
      "key": "115_CR22",
      "unstructured": "Robles-Espinoza CD, Harland M, Ramsay AJ et al (2014) POT1 loss-of-function variants predispose to familial melanoma. Nat Genet 46(5):478–481. \n                    https://doi.org/10.1038/ng.2947",
      "volume": "46",
      "year": "2014"
    },
    {
      "DOI": "10.1093/jnci/dju408",
      "author": "LG Aoude",
      "doi-asserted-by": "publisher",
      "first-page": "408",
      "issue": "2",
      "journal-title": "J Natl Cancer Inst",
      "key": "115_CR23",
      "unstructured": "Aoude LG, Pritchard AL, Robles-Espinoza CD et al (2015) Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma. J Natl Cancer Inst 107(2):408. \n                    https://doi.org/10.1093/jnci/dju408",
      "volume": "107",
      "year": "2015"
    },
    {
      "DOI": "10.1126/science.1230062",
      "author": "S Horn",
      "doi-asserted-by": "publisher",
      "first-page": "959",
      "issue": "6122",
      "journal-title": "Science",
      "key": "115_CR24",
      "unstructured": "Horn S, Figl A, Rachakonda PS et al (2013) TERT promoter mutations in familial and sporadic melanoma. Science 339(6122):959–961. \n                    https://doi.org/10.1126/science.1230062",
      "volume": "339",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s10689-015-9826-8",
      "author": "LG Aoude",
      "doi-asserted-by": "publisher",
      "first-page": "621",
      "issue": "4",
      "journal-title": "Fam Cancer",
      "key": "115_CR25",
      "unstructured": "Aoude LG, Heitzer E, Johansson P et al (2015) POLE mutations in families predisposed to cutaneous melanoma. Fam Cancer 14(4):621–628. \n                    https://doi.org/10.1007/s10689-015-9826-8",
      "volume": "14",
      "year": "2015"
    },
    {
      "DOI": "10.1093/jnci/djy058",
      "author": "CC Teerlink",
      "doi-asserted-by": "publisher",
      "journal-title": "J Natl Cancer Inst",
      "key": "115_CR26",
      "unstructured": "Teerlink CC, Huff C, Stevens J et al (2018) A nonsynonymous variant in the GOLM1 gene in cutaneous malignant melanoma. J Natl Cancer Inst. \n                    https://doi.org/10.1093/jnci/djy058",
      "year": "2018"
    },
    {
      "DOI": "10.1158/1541-7786.MCR-14-0305",
      "author": "CD Robles-Espinoza",
      "doi-asserted-by": "publisher",
      "first-page": "211",
      "issue": "2",
      "journal-title": "Mol Cancer Res MCR",
      "key": "115_CR27",
      "unstructured": "Robles-Espinoza CD, Velasco-Herrera Mdel C, Hayward NK, Adams DJ (2015) Telomere-regulating genes and the telomere interactome in familial cancers. Mol Cancer Res MCR 13(2):211–222. \n                    https://doi.org/10.1158/1541-7786.Mcr-14-0305",
      "volume": "13",
      "year": "2015"
    },
    {
      "DOI": "10.1101/gad.1346005",
      "author": "T Lange de",
      "doi-asserted-by": "publisher",
      "first-page": "2100",
      "issue": "18",
      "journal-title": "Genes Dev",
      "key": "115_CR28",
      "unstructured": "de Lange T (2005) Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19(18):2100–2110. \n                    https://doi.org/10.1101/gad.1346005",
      "volume": "19",
      "year": "2005"
    },
    {
      "DOI": "10.3390/ijms17101619",
      "author": "P Donizy",
      "doi-asserted-by": "publisher",
      "first-page": "1619",
      "issue": "10",
      "journal-title": "Int J Mol Sci",
      "key": "115_CR29",
      "unstructured": "Donizy P, Kaczorowski M, Biecek P, Halon A, Szkudlarek T, Matkowski R (2016) Golgi-related proteins GOLPH2 (GP73/GOLM1) and GOLPH3 (GOPP1/MIDAS) in cutaneous melanoma: patterns of expression and prognostic significance. Int J Mol Sci 17(10):1619. \n                    https://doi.org/10.3390/ijms17101619",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.1038/ng.3373",
      "author": "MH Law",
      "doi-asserted-by": "publisher",
      "first-page": "987",
      "issue": "9",
      "journal-title": "Nat Genet",
      "key": "115_CR30",
      "unstructured": "Law MH, Bishop DT, Lee JE et al (2015) Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma. Nat Genet 47(9):987–995. \n                    https://doi.org/10.1038/ng.3373",
      "volume": "47",
      "year": "2015"
    },
    {
      "DOI": "10.1126/science.1222794",
      "author": "MT Maurano",
      "doi-asserted-by": "publisher",
      "first-page": "1190",
      "issue": "6099",
      "journal-title": "Science",
      "key": "115_CR31",
      "unstructured": "Maurano MT, Humbert R, Rynes E et al (2012) Systematic localization of common disease-associated variation in regulatory DNA. Science 337(6099):1190–1195. \n                    https://doi.org/10.1126/science.1222794",
      "volume": "337",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nature15540",
      "author": "DA Oldridge",
      "doi-asserted-by": "publisher",
      "first-page": "418",
      "issue": "7582",
      "journal-title": "Nature",
      "key": "115_CR32",
      "unstructured": "Oldridge DA, Wood AC, Weichert-Leahey N et al (2015) Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism. Nature 528(7582):418–421. \n                    https://doi.org/10.1038/nature15540",
      "volume": "528",
      "year": "2015"
    },
    {
      "DOI": "10.1128/MCB.01384-09",
      "author": "JB Wright",
      "doi-asserted-by": "publisher",
      "first-page": "1411",
      "issue": "6",
      "journal-title": "Mol Cell Biol",
      "key": "115_CR33",
      "unstructured": "Wright JB, Brown SJ, Cole MD (2010) Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Mol Cell Biol 30(6):1411–1420. \n                    https://doi.org/10.1128/mcb.01384-09",
      "volume": "30",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.cell.2018.06.014",
      "author": "JT Hua",
      "doi-asserted-by": "publisher",
      "first-page": "564",
      "issue": "3",
      "journal-title": "Cell",
      "key": "115_CR34",
      "unstructured": "Hua JT, Ahmed M, Guo H et al (2018) Risk SNP-mediated promoter-enhancer switching drives prostate cancer through lncRNA PCAT19. Cell 174(3):564–575. \n                    https://doi.org/10.1016/j.cell.2018.06.014",
      "volume": "174",
      "year": "2018"
    },
    {
      "DOI": "10.18632/oncotarget.10634",
      "author": "AF Vallarelli",
      "doi-asserted-by": "publisher",
      "first-page": "53127",
      "issue": "33",
      "journal-title": "Oncotarget",
      "key": "115_CR35",
      "unstructured": "Vallarelli AF, Rachakonda PS, Andre J et al (2016) TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation. Oncotarget 7(33):53127–53136. \n                    https://doi.org/10.18632/oncotarget.10634",
      "volume": "7",
      "year": "2016"
    },
    {
      "DOI": "10.1111/j.1529-8019.2012.01499.x",
      "author": "C Badenas",
      "doi-asserted-by": "publisher",
      "first-page": "397",
      "issue": "5",
      "journal-title": "Dermatol Ther",
      "key": "115_CR36",
      "unstructured": "Badenas C, Aguilera P, Puig-Butille JA, Carrera C, Malvehy J, Puig S (2012) Genetic counseling in melanoma. Dermatol Ther 25(5):397–402. \n                    https://doi.org/10.1111/j.1529-8019.2012.01499.x",
      "volume": "25",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.jaad.2018.08.055",
      "author": "SM Swetter",
      "doi-asserted-by": "publisher",
      "journal-title": "J Am Acad Dermatol",
      "key": "115_CR37",
      "unstructured": "Swetter SM, Tsao H, Bichakjian CK et al (2018) Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. \n                    https://doi.org/10.1016/j.jaad.2018.08.055",
      "year": "2018"
    },
    {
      "DOI": "10.1002/ijc.31984",
      "author": "TP Potjer",
      "doi-asserted-by": "publisher",
      "journal-title": "Int J Cancer",
      "key": "115_CR38",
      "unstructured": "Potjer TP, Bollen S, Grimbergen A et al (2018) Multi-gene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families. Int J Cancer. \n                    https://doi.org/10.1002/ijc.31984",
      "year": "2018"
    },
    {
      "DOI": "10.1136/jmedgenet-2018-105610",
      "author": "H Helgadottir",
      "doi-asserted-by": "publisher",
      "journal-title": "J Med Genet",
      "key": "115_CR39",
      "unstructured": "Helgadottir H, Ghiorzo P, van Doorn R et al (2018) Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations. J Med Genet. \n                    https://doi.org/10.1136/jmedgenet-2018-105610",
      "year": "2018"
    },
    {
      "DOI": "10.1002/humu.22592",
      "author": "T Frebourg",
      "doi-asserted-by": "publisher",
      "first-page": "909",
      "issue": "8",
      "journal-title": "Hum Mutat",
      "key": "115_CR40",
      "unstructured": "Frebourg T (2014) The challenge for the next generation of medical geneticists. Hum Mutat 35(8):909–911. \n                    https://doi.org/10.1002/humu.22592",
      "volume": "35",
      "year": "2014"
    },
    {
      "DOI": "10.1186/s12863-017-0479-5",
      "author": "BS Petersen",
      "doi-asserted-by": "publisher",
      "first-page": "14",
      "issue": "1",
      "journal-title": "BMC Genet",
      "key": "115_CR41",
      "unstructured": "Petersen BS, Fredrich B, Hoeppner MP, Ellinghaus D, Franke A (2017) Opportunities and challenges of whole-genome and -exome sequencing. BMC Genet 18(1):14. \n                    https://doi.org/10.1186/s12863-017-0479-5",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.jid.2018.05.023",
      "author": "AE Cust",
      "doi-asserted-by": "publisher",
      "first-page": "2617",
      "issue": "12",
      "journal-title": "J Invest Dermatol",
      "key": "115_CR42",
      "unstructured": "Cust AE, Drummond M, Kanetsky PA et al (2018) Assessing the incremental contribution of common genomic variants to melanoma risk prediction in two population-based studies. J Invest Dermatol 138(12):2617–2624. \n                    https://doi.org/10.1016/j.jid.2018.05.023",
      "volume": "138",
      "year": "2018"
    },
    {
      "DOI": "10.1093/hmg/ddy282",
      "author": "F Gu",
      "doi-asserted-by": "publisher",
      "first-page": "4145",
      "issue": "23",
      "journal-title": "Hum Mol Genet",
      "key": "115_CR43",
      "unstructured": "Gu F, Chen TH, Pfeiffer RM et al (2018) Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma. Hum Mol Genet 27(23):4145–4156. \n                    https://doi.org/10.1093/hmg/ddy282",
      "volume": "27",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s10555-017-9661-5",
      "author": "SA Leachman",
      "doi-asserted-by": "publisher",
      "first-page": "77",
      "issue": "1",
      "journal-title": "Cancer Metastasis Rev",
      "key": "115_CR44",
      "unstructured": "Leachman SA, Lucero OM, Sampson JE et al (2017) Identification, genetic testing, and management of hereditary melanoma. Cancer Metastasis Rev 36(1):77–90. \n                    https://doi.org/10.1007/s10555-017-9661-5",
      "volume": "36",
      "year": "2017"
    }
  ],
  "reference-count": 44,
  "references-count": 44,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-018-00115-3"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Progress report on the major clinical advances in patient-oriented research into familial melanoma (2013–2018)"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "18"
}